Skin Cancer & You

A chemical called candidaspongiolide (CAN) inhibits protein synthesis but also kills cancer cells by triggering caspase 12-dependent programmed cell death, according to an article in the Aug. 26 online issue of the Journal of the National Cancer Institute.

Individuals with a history of nonmelanoma skin cancer are at increased risk for other cancers, according to a study published in the Aug. 26 online issue of the Journal of the National Cancer Institute.

Researchers have identified mebendazole, a drug used globally to treat parasitic infections, as a novel investigational agent for the treatment of chemotherapy-resistant malignant melanoma.